Gunderson Dettmer represented RIGImmune on the deal.RIGImmune, a biopharmaceutical company developing a new class of RNA immunotherapeutics, announced its acquisition of Subintro, a biotechnology company specializing in…
RIGImmune’s Acquisition of Subintro
